PPARG and obesity disorder: It also synergistically regulates adipogenesis with peroxisome proliferator activated receptor gamma (PPARG) and secretory carrier membrane protein 3 (SCAMP3), making it a potential therapeutic target in obesity-related diseases 31, 32.